Clinical Trials Browser

Interventional × Squamous Cell Carcinoma of Head and Neck × Axitinib × Clear all

NCT02762513 2021-05-05

Expansion Trial for Axitinib In Head And Neck Cancer

Phase 2 Completed

29 enrolled 18 charts

Squamous Cell Carcinoma of Head and Neck

NCT01469546 2016-08-29

Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer

Phase 2 Completed

42 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck